In conclusion, our results show that IKKβ promotes KRAS-induced stem-like and malignant traits, which indicates that IKKβ is likely involved in promoting tumour recurrence and aggressiveness, thereby suggesting IKKβ inhibition as a relevant therapeutic approach for KRAS-induced lung cancer. Here, KRAS is linked to lung carcinoma.